Literature DB >> 23834515

Personality disorder dysfunction versus traits: structural and conceptual issues.

Leen Bastiaansen1, Filip De Fruyt2, Gina Rossi1, Christiaan Schotte1, Joeri Hofmans1.   

Abstract

As it stands now, the Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, in press) will maintain the categorical model and criteria distinguishing the 10 personality disorders (PDs) described in the fourth edition of the manual (DSM-IV; American Psychiatric Association, 1994). An alternative diagnostic proposal based on two criteria, being impaired personality functioning and the presence of maladaptive traits, will be referred to a special section for further research and clinical evaluation. Two issues pertaining to this alternative diagnostic approach need further clarification. First, more insight is required in the specific nature of personality dysfunction, its underlying structure, and optimal operationalization. Second, confusion still exists about how personality dysfunction and traits are interconnected and how they both contribute to the PD diagnosis. The current study addresses both issues empirically in a sample of 159 psychiatric patients by (a) investigating the structure of personality functioning as assessed by the Severity Indices of Personality Problems (SIPP-118), and (b) determining the incremental validity of the resulting dysfunction factors vis-à-vis trait domains (measured by the NEO Personality Inventory-Revised [NEO-PI-R]) in explaining DSM-IV PD variance. Trait and dysfunction dimensions were strongly correlated but showed significant, though limited, incremental validity above each other. Implications for the conceptualization of personality pathology are discussed. PsycINFO Database Record (c) 2013 APA, all rights reserved

Entities:  

Mesh:

Year:  2013        PMID: 23834515     DOI: 10.1037/per0000018

Source DB:  PubMed          Journal:  Personal Disord        ISSN: 1949-2723


  7 in total

1.  Associations between changes in normal personality traits and borderline personality disorder symptoms over 16 years.

Authors:  Aidan G C Wright; Christopher J Hopwood; Mary C Zanarini
Journal:  Personal Disord       Date:  2014-11-03

2.  Evaluating the assessment of the ICD-11 personality disorder diagnostic system.

Authors:  Joshua R Oltmanns; Thomas A Widiger
Journal:  Psychol Assess       Date:  2019-01-10

3.  Longitudinal validation of general and specific structural features of personality pathology.

Authors:  Aidan G C Wright; Christopher J Hopwood; Andrew E Skodol; Leslie C Morey
Journal:  J Abnorm Psychol       Date:  2016-11

4.  Personality Disorder and Changes in Affect Consciousness: A 3-Year Follow-Up Study of Patients with Avoidant and Borderline Personality Disorder.

Authors:  Eivind Normann-Eide; Merete Selsbakk Johansen; Tone Normann-Eide; Jens Egeland; Theresa Wilberg
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

5.  Contours of a causal feedback mechanism between adaptive personality and psychosocial function in patients with personality disorders: a secondary analysis from a randomized clinical trial.

Authors:  Ole Klungsøyr; Bjørnar Antonsen; Theresa Wilberg
Journal:  BMC Psychiatry       Date:  2017-06-05       Impact factor: 3.630

6.  A Proposed Classification of ICD-11 Severity Degrees of Personality Pathology Using the Self and Interpersonal Functioning Scale.

Authors:  Dominick Gamache; Claudia Savard; Philippe Leclerc; Maude Payant; Nicolas Berthelot; Alexandre Côté; Jonathan Faucher; Mireille Lampron; Roxanne Lemieux; Kristel Mayrand; Marie-Chloé Nolin; Marc Tremblay
Journal:  Front Psychiatry       Date:  2021-03-18       Impact factor: 4.157

7.  The Relationship between Affect Integration and Psychopathology in Patients with Personality Disorder: A Cross-Sectional Study.

Authors:  Christina Frederiksen; Ole André Solbakken; Rasmus Wentzer Licht; Carsten René Jørgensen; Maria Rodrigo-Domingo; Gry Kjaersdam Telléus
Journal:  Medicina (Kaunas)       Date:  2021-06-16       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.